2014
DOI: 10.1016/j.job.2014.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Membrane transporters in salivary exosomes and microvesicles as biomarkers of systemic or oral disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…However, the effects of Sujiaonori on cardiovascular health have not been investigated. Our preliminary study showed that SBM supplementation increased adiponectin level close to the highest end of normal value in humans (6.42 ng/mL) [ 24 ]. The administration of exogenous adiponectin as a drug is proposed as an alternative therapeutic approach in the management of cardiovascular and metabolic disorders associated with adiponectin deficiency.…”
Section: Resultsmentioning
confidence: 99%
“…However, the effects of Sujiaonori on cardiovascular health have not been investigated. Our preliminary study showed that SBM supplementation increased adiponectin level close to the highest end of normal value in humans (6.42 ng/mL) [ 24 ]. The administration of exogenous adiponectin as a drug is proposed as an alternative therapeutic approach in the management of cardiovascular and metabolic disorders associated with adiponectin deficiency.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast to microvesicles, which are generated by shedding from the plasma membrane, exosomes are derived from multivesicular bodies that are components of the endocytic pathway [89]. Ishikawa and colleagues summarized studies of membrane transporters in salivary exosomes, and of microvesicles as biomarkers of systemic or oral disease [90]. Biomarker discovery is now progressing with regard to analysis of salivary exosomes and microvesicles.…”
Section: Salivary Glandsmentioning
confidence: 99%